WallStSmart
DVAX

Dynavax Technologies Corporation

NASDAQ: DVAX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$15.50
+0.00% today

Updated 2026-02-11

Market cap
$1.82B
P/E ratio
P/S ratio
5.51x
EPS (TTM)
$-0.37
Dividend yield
52W range
$9 – $16
Volume
3.5M

Dynavax Technologies Corporation (DVAX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-22.86M$-37.24M$-32.03M$-17.04M$-33.55M$-51.37M$-47.12M$-43.81M$-58.67M$-73.74M$-92.56M$-107.05M$-77.52M$-131.30M$-121.25M$-92.25M$335.53M$62.72M$100.56M$66.51M
Capital expenditures$562000.00$1.13M$3.65M$4.10M$377000.00$420000.00$1.14M$2.93M$1.63M$1.67M$6.97M$7.76M$669000.00$15.19M$29.40M$11.07M$9.48M$7.14M$4.10M$6.35M
Depreciation
Stock-based comp$1.40M$3.28M$3.53M$3.21M$3.04M$2.41M$5.19M$10.44M$12.34M$6.09M$9.32M$14.13M$14.92M$23.48M$25.46M$13.48M$21.29M$32.91M$42.59M$52.62M
Free cash flow$-23.42M$-38.37M$-35.68M$-21.13M$-33.93M$-51.79M$-48.26M$-46.74M$-60.30M$-75.41M$-99.53M$-114.81M$-78.19M$-146.49M$-150.65M$-103.32M$326.05M$55.58M$96.46M$60.16M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$9.49M$-24.34M$15.52M$26.39M$-4.70M$-20.52M$2.29M$23.24M$-9.68M$-9.28M$405.53M$-233.75M